Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | FABP7 | O15540 | 1/20 | 0.33 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | MDM4 | O15151 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3094306 | 0.80 | FABP5 (0.44) | KMT2AFABP7FABP5MDM4TP53 | |
| SCHEMBL4409222 | 0.80 | FABP5 (0.44) | KMT2AFABP7FABP5MDM4TP53 | |
| SCHEMBL409927 | 0.77 | ALDH1A1 (0.51) | TSHRPOLBALDH1A1KMT2AMAPT | |
| SCHEMBL42370 | 0.69 | EGFR (0.51) | TSHRKMT2AMAPTHTR2AFABP7 | |
| Ammonia Solution, Strong SCHEMBL27729485 | 0.68 | EGFR (0.50) | TSHRKMT2AMAPTHTR2AFABP7 | |
| SCHEMBL8279094 | 0.68 | POLB (0.50) | TSHRPOLBKMT2AMAPTHTR2A | |
| SCHEMBL1568272 | 0.66 | TSHR (0.50) | TSHRPOLBKMT2AMAPTHTR2A | |
| SCHEMBL3660751 | 0.66 | KMT2A (0.43) | TSHRPOLBALDH1A1KMT2AMEN1 | |
| SCHEMBL3655455 | 0.65 | MEN1 (0.39) | TSHRALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL27221202 | 0.65 | MEN1 (0.39) | TSHRALDH1A1KMT2AMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8802193-B2 | Vapor deposition of biomolecules | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2014-08-12 | — | — | US | disclosed |
| US-20100204443-A1 | VAPOR DEPOSITION OF BIOMOLECULES | Ramont At Tel Aviv University Ltd. (IL) | 2010-08-12 | — | — | US | disclosed |
| EP-2198069-A1 | VAPOR DEPOSITION OF BIOMOLECULES | Ramot at Tel-Aviv University Ltd. (IL) | 2010-06-23 | — | — | EP | disclosed |
| WO-2009034566-A1 | VAPOR DEPOSITION OF BIOMOLECULES | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2009-03-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204443-A1 | VAPOR DEPOSITION OF BIOMOLECULES | EPCAM, SHBG, VIM | TSHR 2181/4885POLB 987/4885ALDH1A1 1448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.